日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cells.

小细胞肺癌细胞中 ASCL1 和 NEUROD1 的相互排斥表达是由于致命的共表达不耐受造成的

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-00860-6
Watanabe Hirofumi, Inoue Yusuke, Tsuchiya Kazuo, Asada Kazuhiro, Suzuki Makoto, Ogawa Hiroshi, Tanahashi Masayuki, Watanabe Takuya, Matsuura Shun, Yasuda Kazuyo, Ohnishi Ippei, Imokawa Shiro, Yasui Hideki, Karayama Masato, Suzuki Yuzo, Hozumi Hironao, Furuhashi Kazuki, Enomoto Noriyuki, Fujisawa Tomoyuki, Funai Kazuhito, Shinmura Kazuya, Sugimura Haruhiko, Inui Naoki, Suda Takafumi
细胞生物学
肺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study

奈西妥单抗联合顺铂和吉西他滨治疗晚期肺鳞状细胞癌患者引起的低镁血症的临床影响：NINJA研究的亚组分析

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251318850
Tanzawa, Shigeru; Yoshioka, Hiroshige; Misumi, Toshihiro; Miyauchi, Eisaku; Ninomiya, Kiichiro; Murata, Yasunori; Takeshita, Masafumi; Kinoshita, Fumihiko; Fujishita, Takatoshi; Sugawara, Shunichi; Kawashima, Yosuke; Hashimoto, Kazuki; Mori, Masahide; Miyanaga, Akihiko; Hayashi, Anna; Tanaka, Hisashi; Honda, Ryoichi; Nojiri, Masafumi; Sato, Yuki; Hata, Akito; Ishikawa, Nobuhisa; Kozuki, Toshiyuki; Kawamura, Takahisa; Saito, Go; Yamaguchi, Teppei; Asada, Kazuhiro; Tetsumoto, Satoshi; Tanaka, Hiroshi; Watanabe, Satoshi; Umeda, Yukihiro; Yamaguchi, Kakuhiro; Nishii, Kazuya; Tsuruno, Kosuke; Misumi, Yuki; Kuraishi, Hiroshi; Yoshihara, Ken; Nakao, Akira; Kubo, Akihito; Yokoyama, Toshihiko; Watanabe, Kana; Seki, Nobuhiko
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study

30天内出现皮肤疾病是接受奈西妥单抗联合吉西他滨和顺铂治疗的肺鳞状细胞癌患者的良好预后因素：NINJA研究的亚组分析

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359241312503
Kinoshita, Fumihiko; Tanzawa, Shigeru; Misumi, Toshihiro; Yoshioka, Hiroshige; Miyauchi, Eisaku; Ninomiya, Kiichiro; Murata, Yasunori; Takeshita, Masafumi; Yamaguchi, Masafumi; Sugawara, Shunichi; Kawashima, Yosuke; Hashimoto, Kazuki; Mori, Masahide; Miyanaga, Akihiko; Hayashi, Anna; Tanaka, Hisashi; Honda, Ryoichi; Nojiri, Masafumi; Sato, Yuki; Yamamoto, Ken; Masuda, Ken; Kozuki, Toshiyuki; Kawamura, Takahisa; Suzuki, Takuji; Yamaguchi, Teppei; Asada, Kazuhiro; Tetsumoto, Satoshi; Tanaka, Hiroshi; Watanabe, Satoshi; Umeda, Yukihiro; Yamaguchi, Kakuhiro; Kuyama, Shoichi; Tsuruno, Kosuke; Misumi, Yuki; Kuraishi, Hiroshi; Yoshihara, Ken; Nakao, Akira; Kubo, Akihito; Yokoyama, Toshihiko; Watanabe, Kana; Seki, Nobuhiko
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies

接受免疫检查点抑制剂治疗的晚期非小细胞肺癌患者停药后的生存情况：前瞻性队列研究的汇总分析

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100847
Inoue, Yusuke; Kitahara, Yoshihiro; Karayama, Masato; Asada, Kazuhiro; Nishimoto, Koji; Matsuura, Shun; Hashimoto, Dai; Fujii, Masato; Matsui, Takashi; Inami, Nao; Toyoshima, Mikio; Matsuda, Hiroyuki; Ikeda, Masaki; Niwa, Mitsuru; Kaida, Yusuke; Sato, Masaki; Ito, Yasuhiro; Yasui, Hideki; Suzuki, Yuzo; Hozumi, Hironao; Furuhashi, Kazuki; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Inui, Naoki; Suda, Takafumi
Checkpoint
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials

奥氮平联合三联止吐疗法预防卡铂引起的恶心：两项临床试验的汇总分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14985-1
Kojima, Suguru; Inui, Naoki; Suzuki, Takahito; Tanaka, Kazuki; Karayama, Masato; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Nishimoto, Koji; Matsuura, Shun; Hashimoto, Dai; Matsui, Takashi; Asada, Kazuhiro; Suda, Takafumi
发表日期：2025
文献求助 收藏

Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial

奥氮平联合三联止吐疗法预防卡铂引起的恶心和呕吐：一项随机、双盲、安慰剂对照的III期试验

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00278
Inui, Naoki; Suzuki, Takahito; Tanaka, Kazuki; Karayama, Masato; Inoue, Yusuke; Mori, Kazutaka; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Fujisawa, Tomoyuki; Matsuura, Shun; Nishimoto, Koji; Matsui, Takashi; Asada, Kazuhiro; Hashimoto, Dai; Fujii, Masato; Niwa, Mitsuru; Uehara, Masahiro; Matsuda, Hiroyuki; Koda, Keigo; Ikeda, Masaki; Inami, Nao; Tamiya, Yutaro; Kato, Masato; Nakano, Hideki; Mino, Yasuaki; Enomoto, Noriyuki; Suda, Takafumi
发表日期：2024
文献求助 收藏

Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II study

口服泼尼松龙治疗6周后免疫相关性肺炎复发的危险因素：一项II期研究的随访分析

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-024-03284-3
Karayama, Masato; Inui, Naoki; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Asada, Kazuhiro; Nishimoto, Koji; Fujii, Masato; Matsui, Takashi; Matsuura, Shun; Hashimoto, Dai; Toyoshima, Mikio; Ikeda, Masaki; Matsuda, Hiroyuki; Inami, Nao; Kaida, Yusuke; Funayama, Satoshi; Ichikawa, Shintaro; Goshima, Satoshi; Suda, Takafumi
肺炎
免疫/内分泌
发表日期：2024
文献求助 收藏

Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study

为期六周的口服泼尼松龙治疗免疫相关性肺炎：一项单臂 II 期研究

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-007056
Karayama, Masato; Inui, Naoki; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Asada, Kazuhiro; Uto, Tomohiro; Fujii, Masato; Matsui, Takashi; Matsuura, Shun; Hashimoto, Dai; Toyoshima, Mikio; Ikeda, Masaki; Matsuda, Hiroyuki; Inami, Nao; Kaida, Yusuke; Funayama, Satoshi; Ichikawa, Shintaro; Goshima, Satoshi; Suda, Takafumi
肺炎
免疫/内分泌
发表日期：2023
文献求助 收藏

Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy

细胞因子谱分析可确定循环IL-6和IL-15是接受抗PD-1/PD-L1阻断治疗的非小细胞肺癌患者的预后分层指标。

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-023-03453-z
Inoue, Yusuke; Inui, Naoki; Karayama, Masato; Asada, Kazuhiro; Fujii, Masato; Matsuura, Shun; Uto, Tomohiro; Hashimoto, Dai; Matsui, Takashi; Ikeda, Masaki; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Suda, Takafumi
肺癌
肿瘤
IL-15
肿瘤免疫
PD-L1
细胞生物学
IL-6
PD-1
免疫/内分泌
发表日期：2023
文献求助 收藏

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study

日本一项多中心回顾性研究，旨在评估免疫检查点抑制剂治疗后，奈西妥单抗联合顺铂和吉西他滨治疗晚期鳞状细胞肺癌的疗效：NINJA 研究

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2023.100593
Murata, Yasunori; Tanzawa, Shigeru; Misumi, Toshihiro; Yoshioka, Hiroshige; Miyauchi, Eisaku; Ninomiya, Kiichiro; Takeshita, Masafumi; Ito, Kensaku; Okamoto, Tatsuro; Sugawara, Shunichi; Kawashima, Yosuke; Hashimoto, Kazuki; Mori, Masahide; Miyanaga, Akihiko; Hayashi, Anna; Tanaka, Hisashi; Honda, Ryoichi; Nojiri, Masafumi; Sato, Yuki; Hata, Akito; Masuda, Ken; Kozuki, Toshiyuki; Kawamura, Takahisa; Suzuki, Takuji; Yamaguchi, Teppei; Asada, Kazuhiro; Tetsumoto, Satoshi; Tanaka, Hiroshi; Watanabe, Satoshi; Umeda, Yukihiro; Yamaguchi, Kakuhiro; Kuyama, Shoichi; Tsuruno, Kosuke; Misumi, Yuki; Kuraishi, Hiroshi; Yoshihara, Ken; Nakao, Akira; Kubo, Akihito; Yokoyama, Toshihiko; Watanabe, Kana; Seki, Nobuhiko
Checkpoint
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏